Primary Care Clinics in St Simons Island, GA Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 St Simons Island Clinic Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 284 Redfern Vlg, St Simons Island, GA 31522 Phone: 912-634-9092 Fax: 201-221-8640 |
House Calls Of Coastal Georgia, Pc Family Medicine Medicare: Medicare Enrolled Practice Location: 811 Sand Dollar Trce, St Simons Island, GA 31522 Phone: 912-580-6913 Fax: 912-265-2859 |
Macmed Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 2927 Demere Rd, Atten: Dr Andrew T Mcrae, St Simons Island, GA 31522 Phone: 912-638-1999 |
Gene S. Kennedy M.d. P.c. Family Medicine Medicare: Medicare Enrolled Practice Location: 101 Heron Walk, St Simons Island, GA 31522 Phone: 912-634-2651 Fax: 912-634-2653 |
Artman Medical Services, Pc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Main St, Suite 100, St Simons Island, GA 31522 Phone: 912-638-7688 Fax: 912-638-6668 |
Coastal Community Health Services, Inc. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 7000 Wellness Way Ste 7230, St Simons Island, GA 31522 Phone: 912-466-5840 |
Margaret F. Carter, Md, Pc Family Medicine Medicare: Medicare Enrolled Practice Location: 282 Redfern Vlg, St Simons Island, GA 31522 Phone: 912-634-2394 |
News Archive
Avoidant grievers unconsciously monitor and block mind-wandering contents, study shows
People who are grieving a major loss, such as the death of a spouse or a child, use different coping mechanisms to carry on with their lives. Psychologists have been able to track different approaches, which can reflect different clinical outcomes.
Pharmaceutical Executive Magazine names COPAXONE therapy as 2014 "Brand of The Year"
Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.
Vioxx withdrawal raises many questions concerning drug policy
Daniel H. Solomon, M.D., M.P.H., from Brigham and Women's Hospital, Boston, and Jerry Avorn, M.D., of Harvard University School of Medicine, write in the January 24 issue of Archives of Internal Medicine that the withdrawal of rofecoxib (Vioxx) from the market in September 2004 by its manufacturer, Merck & Co., "raises many questions concerning drug policy, scientific evidence, and treatment alternatives.
Extra weight gain during lockdown could have significant health implications, cardiologist warns
Many more of us could have diabetes and high blood pressure if we don't lose the extra weight we've put on during lockdown, a renowned cardiologist at Keele University has warned.
Study shows strawberries can provide immense health benefits
When it comes to eating healthy, most people know it's a good long-term choice, but what they may not know is that eating certain foods daily can provide immediate health benefits.
› Verified 9 days ago